Results 131 to 140 of about 343,899 (350)
Clinical Pharmacology &Therapeutics, EarlyView.Verekitug, a novel, high‐affinity, fully human monoclonal antibody targeting thymic stromal lymphopoietin receptor (TSLPR), is in development as a potential treatment for severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), and chronic obstructive pulmonary disease (COPD).
Dave Singh +9 more
wiley +1 more source
5.3 Ontogeny of T-cell surface molecules and receptors in the thymus [PDF]
, 1992 Marie Paule Defresne +9 more
openalex +1 more source
TimeFlow 2: An Unsupervised Cell Lineage Detection Method for Flow Cytometry Data
Cytometry Part A, EarlyView.TimeFlow 2 is a new method for cell lineage inference in flow cytometry data. It constructs cell state paths along pseudotime and aggregates them into biologically informative groups. It allows tracking of cytometry markers within each automatically inferred lineage.
Margarita Liarou +2 more
wiley +1 more source
Lymphatic involution and early mortality in the young chicken produced by 2.2 GeV protons [PDF]
, 1972 Young single-comb white Leghorn cockerels were subjected to single acute doses of either 2.2 GeV protons or 250 kVp X-rays. Since young chickens exposed in the lethal range die within 48 hours of exposure, an hourly tabulation of deaths was recorded for ...
Montour, J. L., Shellabarger, C. J.
core +1 more source
The Role of S1PR1 Agonism in Thymus-Dependent T-Cell Regeneration and Graft-vs.-Tumor Activity Following Experimental Allogeneic Hematopoietic Stem Cell Transplantation [PDF]
, 2018 Madeleine Vollmer, Werner Krenger
openalex +1 more source
Phytochemical Investigation of Thymus zygis L. and Salvia officinalis L. Collected from Fez-Meknes Region, Morocco [PDF]
, 2023 Asmae Benabderrahmane +4 more
openalex +1 more source
RORγt‐APCs: The New Masters of Oral Tolerance
Barrier Immunity, EarlyView.ABSTRACT Oral tolerance is defined by the hypo‐responsiveness of our body to fed antigens, and its failure can lead to immune‐mediated diseases, such as allergy, chronic inflammation and autoimmune diseases. Decades of research have demonstrated that antigen‐presenting cells (APCs) promote oral tolerance by inducing regulatory T cells (Tregs) and/or ...
Thierry Gauthier, WanJun Chen
wiley +1 more source